AzTrials
AzTrials

Musculoskeletal PainEarly Phase 1NCT04204486

Health, Wellbeing and Performance in Law Enforcement Workers

A Early Phase 1 study testing Exercise in people with Musculoskeletal Pain and Cognitive Change, run by University College, London at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to assess current health and fitness of law enforcement workers in various roles, and to evaluate the impact of an exercise intervention on markers on physical and mental wellbeing in this population. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteUnited Kingdom
Study dates
3 Jan 2020to 30 Jun 2023
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Healthy
  • Working in law enforcement

Who cannot join

  • Participants with any form of physical injury, neuromuscular, respiratory or cardiovascular condition

Trial locations and contacts

1 site in 1 country.

Flaminia Ronca, PI contact

02034472838

f.ronca@ucl.ac.uk

Paul Burgess, CoPI contact

p.burgess@ucl.ac.uk

United Kingdom1 site, 1 recruiting
  • The ISEH

    London, W1T 7HA

    Flaminia Ronca, PI, 02034472838, f.ronca@ucl.ac.uk

    Recruiting

Other trials in United Kingdom

About this study

Official title: A Multidisciplinary Evaluation on the Effects of an Exercise Intervention on Markers of Health, Wellbeing and Performance in Law Enforcement Workers

This study aims to assess current health and fitness of law enforcement workers in various roles, and to evaluate the impact of an exercise intervention on markers on physical and mental wellbeing in this population.

The intervention will consist of an exercise programme specifically targeted at improving, physical fitness and reducing musculoskeletal pain. Participants will be randomised to three groups: a face to face intervention group, an online intervention group an a control group.

Read more

Self-reported physical health, musculoskeletal complaints, quality of sleep and occupational stress will be measured via questionnaires. Pre and post measures of fitness will be measured via functional strength testing and a cardiopulmonary exercise test. Pre and post cognitive function will be measured via computer-based cognitive tests and brain functional near-infrared spectroscopy (fNIRS). Systemic inflammation will be measured via hsCRP. Risk of typeII diabetes will be measured via HbA1c. Daily physical activity and quality of sleep will be measured via accelerometry and heart rate telemetry.

It is hypothesised that, upon completion of the programme, there will be an improvement in cardiovascular fitness and physical strength, reduced musculoskeletal pain, improved cognitive readiness and improved overall mental health and wellbeing.

Read the detailed description

Randomisation Participants will be stratified by shift pattern and by role, and will be randomised to one of three intervention arms using permuted blocks of 3 and 6.

Self-reported information After the consent forms and PAR-Q have been signed, an Operational Police Stress Questionnaire (PSQ-Op), Impact of Events Scale (IES-R), a Leeds Sleep Evaluation (LSE) and an overall health and injury questionnaire (Nordic scale) will be sent to the officers via email using Gorilla software in December 2019.

Participants will be interviewed on the quality of their dietary intake. Trained nutrition research students will collect responses to a Food Frequency Questionnaire (FFQ) in a face to face interview.

Wearables Participants will be given wearable devices to measure their levels of physical activity during an 8-day period (full on and off shift cycle) before the intervention: the heart rate of each participant will be monitored via a Polar heart rate monitor and movement will be measured via an accelerometer worn on the non-dominant wrist (Actigraph, Pensacola, USA). Levels of physical activity, quality of sleep and heart rate variability will be processed as anonymised data on a computer. Participants will be asked to log the quality of their sleep every time they wake up from a long sleep via a Pittsburgh Sleep Quality Index (PSQI). No individuals other than the researchers will have access to the data from the wearable devices. The data will be downloaded from the device and stored in a password-protected file, on an encrypted, password-protected UCL computer in a locked cabinet. After downloading the data to the computer, the wearable device will be formatted.

Oral tests Participant oral health will be assessed on site at the respective stations in January. Oral inflammation has been shown to affect systemic health with cross-sectional evidence suggesting a negative effect on physical activity in Brazilian police. Oral health will be assessed using validated outcome measures routinely employed in both NHS dental practice and research, including: the visual assessment of inflammation of the gum edge and measurement of the depth of the gum pocket (mm) following gentle probing with a calibrated blunt probe; and tooth decay screening assessed through standard clinical methods. Together, these assessments take approximately 15 minutes.

Saliva will be analysed to investigate the effect of the physical activity intervention on the health outcomes. The researchers will collect around 5ml of saliva using standard methods by asking participants to drool into collection pots. The samples will be frozen then analysed for biomarkers related to stress and inflammation. The samples will be collected at the first and last study visits.

Physical and Cognitive tests Participants will then attend a physical screening session at the Institute of Sport, Exercise and Health (ISEH) at UCL. The session will consist of a functional strength test (triple hop, jumps to fatigue on jump mat, successful press-ups one minute, successful inverted rows in one minute). Cardiorespiratory performance will be measured via a Cardio-Pulmonary Exercise Test (CPET) on a treadmill (h/p/cosmos) using the Bruce protocol. During the CPET, Heart Rate will be monitored via a Polar heart rate monitor, and breath-by-breath analysis will be performed with a Vyair gas analyser system to collect VO2 data.

Biomarkers (hsCRP, HbA1c) will be analysed by collecting one blood capillary sample with a finger prick. The capillary is then inserted in an Eppendorf tube and inserted into a Eurolyser Cube (Eurolyser, Salsburg, Austria) to measure markers of inflammation.

Cognitive tests will be performed before and after the CPET. Participants will undergo Source \& Context Memory, inhibition and SOSI tests on an encrypted computer, using the e-Prime software. The cognitive tasks will be standard-format computerised tasks that are used in e.g. studies of drug effects upon cognition, or in experiments looking at the effects of sleep deprivation, or the effects of exercise upon people's abilities to think and remember. Participants are shown pictures and words on a laptop and have to make responses using button boxes of the keyboard. The number of errors and reaction times are recorded. The tests are not stressful and no deception is involved. There are several thousands of publications in the literature that have used these or very similar procedures, and the investigators know of no case where these have caused harm to the participants.

In order to record brain activity during the cognitive tests, functional near-infrared spectroscopy (fNIRS) will be used (Shimadzu LightNIRS). An fNIRS cap placed on the participant's head records brain activity using infra-red light.

Intervention After all screening is complete, participants will be randomly allocated to one of three groups: face to face exercise program (F2F), online exercise program delivered via mobile app (APP) and control (C). The F2F group will receive three exercise training sessions, three times a week for 8 weeks, delivered in person by a strength and conditioning coach at the police station. The exercise intervention will take the format of circuit training using body weight and elastic resistance, focusing on strength endurance and core stability. The APP group will receive online instructions via an app (TeamBuilder) on how to perform the same exercise programme at home. The C group will not receive an intervention.

Behaviour change (to retain levels of physical activity during and after the intervention) will be facilitated by encouraging buddying during the exercise intervention, and by assigning points to the groups based on attendance. There will be two F2F groups and 2 APP groups (Heathrow vs Wood Green). A competitive element will be added between respective F2F and APP groups by assigning 1 point for each participant that attends the session, +2 extra points if all participants attend. Attendance will be kept by the coach for the F2F group. Participants on the APP group will be asked to take a picture of themselves after having completed each session as proof of completion. The coach will monitor compliance for both groups with at attendance spreadsheet.

Post testing After the 8-week training programme is complete, the participants will repeat the same questionnaires, wearables period, fitness tests and cognitive tests that were used in the pre-intervention testing.

Behaviour change will be assessed via a focus group after the intervention. The focus groups will be aimed at gathering feedback on the intervention and on attitudes towards exercise following the COM-B model, including participant experience and whether they felt that the intervention effectively improved their wellbeing.

Being tested
Exercise
Keywords
Exercise, Strength, Source Memory, Context Memory, Inhibition, Executive Function, SOSI, Shift work, police, law enforcement, military, Oral health, Quality of Sleep, Cognition, Fitness
Medical subject headings
Musculoskeletal Pain, Occupational Stress, Inflammation, Motor Activity, Inhibition, Psychological, Sleep Initiation and Maintenance Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseBehavioural

    Functional strength training, 1 hour, 3 times a week.

Study groups in NCT04204486
Study groupRoleWhat they receive
Face to face exercise interventionExperimentalParticipants will participate in face to face exercise programme delivered by a strength and conditioning coach. Sessions will last 1 hour, 3 times a week, and will be offered at the work place. The coach will register attendance in order to monitor compliance.
Receives: Behavioral: Exercise
Online exercise interventionActive comparatorParticipants will be given the same training programme as the face to face group, but via an online app. Sessions should last 1 hour and should be completed 3 times a week. Participants will be asked to post a "work-out picture" on the social platform of the app as proof that they completed their session.
Receives: Behavioral: Exercise
ControlNo interventionThis group will undergo all pre and post tests, but will not receive an intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in musculoskeletal pain: measured via the Nordic Scale

    Complaints of musculoskeletal pain, collected via a Nordic Scale. The scale runs from 0-10, where 0 is no pain at all and 10 is worst imaginable pain.

    Measured: Change from baseline after 8 weeks

  2. Change in upper body strength endurance (push)

    Numbers of pushups performed in one minute with good form (eg. not dipping the hips and using full range of motion)

    Measured: Change from baseline after 8 weeks

  3. Change in upper body strength endurance (pull)

    Numbers of inverted rows performed in one minute with good form (eg. not dipping the hips and using full range of motion)

    Measured: Change from baseline after 8 weeks

  4. Change in leg strength, measured via the Triple Hop test

    Participants perform three hops on one leg. The total distance (cm) of the three hops is recorded. The test is repeated for both legs.

    Measured: Change from baseline after 8 weeks

  5. Change in lower limb power

    Participants perform a counter-movement jump on a jump mat (Chronojump). Power (Watts) is recorded.

    Measured: Change from baseline after 8 weeks

  6. Change in hand grip strength

    Hand grip strength (Newtons) is measured with a hand-held dynamometer.

    Measured: Change from baseline after 8 weeks

  7. Change in Cardiovascular fitness

    measured via CPET test

    Measured: Change from baseline after 8 weeks

Secondary outcomes (18)
  1. Change in simple reaction time after maximal exercise

    Measured via cognitive tests on a computer screen using the ePrime software, which require the participant to press a key on the key board after seeing a specific image. Reaction time (milliseconds) and number of errors are recorded.

    Measured: Change from baseline after a single bout of maximal exercise (CPET)

  2. Change in simple reaction time after an exercise intervention

    Measured via cognitive tests on a computer screen using the ePrime software, which require the participant to press a key on the key board after seeing a specific image. Reaction time (milliseconds) and number of errors are recorded.

    Measured: Change from baseline after 8 weeks

  3. Change in Motor Inhibition after maximal exercise

    Measured via cognitive tests on a computer screen using the ePrime software, which require participants to press a key on the keyboard every time a new image appears on the screen, except when a specific picture appears (specified in the instructions), in which case they must refrain from pressing the key. Reaction time (milliseconds) and number of errors are recorded.

    Measured: Change from baseline after a single bout of maximal exercise (CPET)

  4. Change in Motor Inhibition after an exercise intervention

    Measured via cognitive tests on a computer screen using the ePrime software, which require participants to press a key on the keyboard every time a new image appears on the screen, except when a specific picture appears (specified in the instructions), in which case they must refrain from pressing the key. Reaction time (milliseconds) and number of errors are recorded.

    Measured: Change from baseline after 8 weeks

  5. Change in source memory after maximal exercise

    Measured via cognitive tests on a computer screen using the ePrime software, which require participants to recall specific details from an image shown previously. Reaction time (milliseconds) and number of errors are recorded.

    Measured: Change from baseline after a single bout of maximal exercise (CPET)

  6. Change in source memory after an exercise intervention

    Measured via cognitive tests on a computer screen using the ePrime software, which require participants to recall specific details from an image shown previously. Reaction time (milliseconds) and number of errors are recorded.

    Measured: Change from baseline after 8 weeks

  7. Changes in blood flow in the prefrontal cortex after maximal exercise

    Changes in saturation of oxy- and de-oxygenated blood in the prefrontal cortex of the brain as measured by near infrared spectroscopy (fNIRS). These two signals are then combined into one measure by using the correlation-based signal improvement (CBSI) procedure.

    Measured: Change from baseline after a single bout of maximal exercise (CPET)

  8. Changes in blood flow in the prefrontal cortex after an exercise intervention

    Changes in saturation of oxy- and de-oxygenated blood in the prefrontal cortex of the brain as measured by near infrared spectroscopy (fNIRS). These two signals are then combined into one measure by using the correlation-based signal improvement (CBSI) procedure.

    Measured: Change from baseline after 8 weeks

  9. Cognitive failures

    Measures via cognitive failures questionnaire. The questionnaire gives a score from 0-100, where a high number shows poor cognitive function.

    Measured: Change from baseline after 8 weeks

  10. Gum inflammation (oral health)

    visual assessment of inflammation of the gum edge and measurement of the depth of the gum pocket (mm) following gentle probing with a calibrated blunt probe

    Measured: Baseline

  11. Change in levels of Occupational Stress

    measured via Operational Police Stress Questionnaire (PSQ-Op),participants score 20 questions on a scale of 1-7, where 1 is no stress t alland 7 is very high stress.

    Measured: Change from baseline after 8 weeks

  12. Change in levels of Trauma

    measured via Impact of Events Scale (IES-R) questionnaires. Scores range from 0 - 88, where 0 is no trauma and 88 is severe trauma. A score of 24 or more signifies that PTSD is a clinical concern. 33 and above represents the best cutoff for a probable diagnosis of PTSD.

    Measured: Change from baseline after 8 weeks

  13. Change in Lifestyle - Physical activity levels

    Levels of physical activity measured via accelerometers and heart rate monitors using actigraphy, processed through the Actilife software. The software uses the two wearable devices to calculate proportions of the day spent in sedentary, light, moderate and vigorous activity. These measures are combined to show percentage of the day spent in each activity level.

    Measured: Change from baseline after 8 weeks

  14. Changes in Quality of Sleep (objective)

    Measured via accelerometers and heart rate monitors through Actilife software, which combined the heart rate and movement data from the wearable devices, providing a Sleep Efficiency score, reported as a percentage. A high percentage denotes good quality of sleep.

    Measured: Change from baseline after 8 weeks

  15. Changes in Quality of Sleep (subjective)

    Measured via and Pittsburg Sleep Quality Index (PSQI). The scale includes 7 items, each item is weighted on a 0-3 interval scale. The global PSQI score is then calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality.

    Measured: Change from baseline after 8 weeks

  16. Changes in Systemic inflammation

    hsCRP via Eurolyser

    Measured: Change from baseline after 8 weeks

  17. Changes in Risk of type II diabetes

    HBa1c via Eurolyser

    Measured: Change from baseline after 8 weeks

  18. Nutrition

    Eating habits assessed vi a Food Frequency Questionnaire, administered via an interview

    Measured: Change from baseline after 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2019
  2. Study start3 Jan 2020
  3. Primary completion30 May 2020 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomised control trial. Participants will be stratified by shift pattern and by role, and will be randomised to one of three intervention arms using permuted blocks of 3 and 6.
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04204486
Sponsor's protocol ID
13985/004
Status last verified
Mar 2020
First submitted
3 Dec 2019
Last updated
24 Mar 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All data will be anonymised and will be reported as group mean data

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Exercise in people with Musculoskeletal Pain and Cognitive Change, run by University College, London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Flaminia Ronca, PI (02034472838, f.ronca@ucl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in musculoskeletal pain: measured via the Nordic Scale (time frame: Change from baseline after 8 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in